Pharmaceutical Discovery and Preclinical Development1

 View Only
  • 1.  OSD on June 18th: Harnessing Multi-omics for Exploratory Biomarker Development (Part 2)

    Community Leadership
    Posted 05-29-2024 08:30

    The Biomarkers and Precision Medicine (BPM) and Bioanalytical (BA) Communities are hosting a series of Open Scientific Discussions (OSDs) on Multi-omics in Drug Development.  Please join us for the second OSD in the series hosted on June 18th, 12 - 1 pm ET:

    Part 2: Harnessing Multi-omics for Exploratory Biomarker Development

    ·       How can multi-omics address important questions in drug R&D and expedite development?

    ·       How have recent developments in proteomics altered the discovery and translation of candidate biomarkers?

    ·       How can spatial metabolomics map tissue specific metabolism related to disease and identify new drug targets?

    Discussion Leaders:

    Veronica Anania (Genentech) and Gary Patti (Washington University)

    Organized by:  Jurre Kamphorst (Olaris), Iris Qiu (Novartis), Ayuko Ota-Selik and Jianing Zeng (BMS)

     

    We start at 12:00 ET sharp. To avoid interruptions, please dial in before noon and mute yourself until Q&A starts.

    (Please remain on mute unless asking questions)

    When: Tuesday, June 18, 2024, 12 pm – 1 pm ET

    WherePlease join from your computer, tablet or smartphone.
    https://global.gotomeeting.com/join/305789893

    You can also dial in using your phone.
    United States: 
    +1 (872) 240-3412
    Access Code: 305-789-893
    Join from a video-conferencing room or system.
    Dial in or type: 
    67.217.95.2 or inroomlink.goto.com
    Meeting ID: 305 789 893
    Or dial directly: 
    [email protected] or 67.217.95.2##305789893
    New to GoToMeeting? Get the app now and be ready when your first meeting starts:
    https://global.gotomeeting.com/install/305789893

    Please feel free to share with colleagues who may be interested in this topic.

     

    Thank you,

    The AAPS BPM and BA Community Leadership Teams



    ------------------------------
    Karen Quadrini, PhD
    Director, Clinical Biomarkers
    Prothena Biosciences
    Brisbane, CA
    [email protected]

    Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
    ------------------------------


  • 2.  RE: OSD on June 18th: Harnessing Multi-omics for Exploratory Biomarker Development (Part 2)

    Community Leadership
    Posted 06-03-2024 10:20

    Thank you so much for sharing this opportunity, Karen!



    ------------------------------
    Bo Tokarski Ph.D.
    Manager, Analytical Chemistry
    Charles River Laboratories Ashland LLC
    Ashland OH
    [email protected]

    Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
    ------------------------------



  • 3.  RE: OSD on June 18th: Harnessing Multi-omics for Exploratory Biomarker Development (Part 2)

    Community Leadership
    Posted 06-04-2024 10:52

    Of course! Hope members of the community are available and able to join in the discussion.  It should be a good one!



    ------------------------------
    Karen Quadrini, PhD
    Director, Clinical Biomarkers
    Prothena Biosciences
    Brisbane, CA
    [email protected]

    Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
    ------------------------------